Clinical Trial Details

EORTC-1506

Back to Clinical Trials Database

A phase II multicenter study comparing the efficacy of the oral angiogenesis inhibitor nintedanib with the intravenous cytotoxic compound ifosfamide for treatment of patients with advanced metastatic soft tissue sarcoma after failure of systemic non-oxazaphosporine-based first line chemotherapy for inoperable disease "ANITA"

Study documentation

Trial Status All trial activities ended
Dates Date of activation: 07-Jul-2017
Date Step1 close: 22-Nov-2019
Data management at EORTC Yes
Design Phase 2
Randomized open label
Targeted Sample size EORTC Groups: 158 - All Groups: 158
Treatment
Study Staff
Type of cancer
Participating groups
Protocol summary http://clinicaltrials.gov/ct/show/NCT02808247
NCT number NCT02808247
EudraCT 2016-002093-12